PG2® Lyo. Injection

PG2® Lyo. Injection
Product Description

Cancer-related fatigue (CRF) treatment (Astragalus polysaccharides injection 500 mg). PhytoHealth at CPHI-Milan 2024. Contact us: [email protected].

-The first medicine approved for cancer-related fatigue treatment
-Compliance with global standards of botanical medicine(GACP and PIC/S GMP)
-Patients with higher Karnofsky Performance Status respond better to PG2 treatment
-Dual MOA, hematopoiesis and immune-modulation

Read more Show less

PhytoHealth Corporation

  • TW
  • 2024
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Licensee
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Out-licensing specialist
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    -The first medicine approved for cancer-related fatigue treatment
    -Compliance with global standards of botanical medicine(GACP and PIC/S GMP)
    -Patients with higher Karnofsky Performance Status respond better to PG2 treatment
    -Dual MOA, hematopoiesis and immune-modulation
More specifications Fewer specifications

PhytoHealth Corporation

  • TW
  • 2024
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Licensee
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Out-licensing specialist
View company profile

More Products from PhytoHealth Corporation (1)

  • Oraphine® Soft Capsules

    Product Oraphine® Soft Capsules

    Relieve moderate to severe acute pain (Nalbuphine HCl 60mg). PhytoHealth at CPHI-Milan 2024. Contact us: [email protected].
    - First oral nalbuphine formulation
    - Patented technology to improve oral bioavailability
    - Fast onset within 15~30 mins
    - Ceiling...

PhytoHealth Corporation resources (1)